Navigation

Eli Lilly pauses trial of antibody drug over safety concern

Eli Lilly pauses trial of antibody drug over safety concern
U.S. drugmaker Eli Lilly said that the government-sponsored clinical trial of its COVID-19 antibody treatment similar to one taken by President Donald Trump has been paused because of a safety concern.

Share

Post A Comment:

0 comments:

Leave a comment. Thanks!